Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Fair Value (Tables)

Fair Value (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of financial assets measured at fair value on a recurring basis

Financial assets measured at fair value on a recurring basis are categorized in the tables below based upon the lowest level of significant input to the valuations (in thousands):

	Assets at Fair Value as of March 31, 2015
	Level 1		Level 2		Level 3		Total
Money market funds	$	26,978	$	—	$	—	$	26,978
Government-sponsored enterprise securities	—		42,129		—		42,129
Corporate bonds and commercial paper	—		90,905		—		90,905
Total	$	26,978	$	133,034	$	—	$	160,012

	Assets at Fair Value as of December 31, 2014
	Level 1		Level 2		Level 3		Total
Money market funds	$	10,027	$	—	$	—	$	10,027
U.S. treasury bills	—		2,010		—		2,010
Government-sponsored enterprise securities	—		45,786		—		45,786
Corporate bonds and commercial paper	—		85,161		—		85,161
Total	$	10,027	$	132,957	$	—	$	142,984